Leica Biosystems Melbourne Finalist for 2023 Victorian Manufacturing Hall of Fame Award

The company’s latest Advanced Staining Solution, BOND-PRIME, is primarily manufactured in Melbourne, Australia

MELBOURNE – Leica Biosystems is pleased to announce that the company is a finalist for the 2023 Victorian Manufacturing Hall of Fame Award for Manufacturer of the Year (Large Business). The Leica Biosystems facility in Melbourne was established in 2000. Today in 2023 more than 200 associates develop and manufacture solutions to be shipped to laboratories around the world.

The company’s latest flagship product, the BOND-PRIME Advanced Staining Solution, is a system that delivers all elements of Universal Access, enabling lab technicians to load any slides in any combination, with any reagent, at any time.

“While Leica Biosystems has a broad global footprint, a number of our flagship products including the new innovative BOND-PRIME Advanced Staining Platform are proudly made here at our Mount Waverley facility, which has been in operation for more than 20 years.” said Will Day, Vice President & General Manager, Advanced Staining Instruments.

The Victorian Manufacturing Hall of Fame Awards celebrates the achievements of exceptional manufactures across the state.

This is not the first recognition of its kind for Leica Biosystems. The company previously won the High Growth Sector – Medical Technology and Pharma Award at the 2018 Victorian Manufacturing Hall of Fame awards ceremony. In 2019 and 2022, the company was also a finalist for Manufacturer of the Year (Large Business).

About the BOND-PRIME Advanced Staining Solution

The BOND-PRIME staining platform delivers high productivity, featuring Universal Access, and can seamlessly adapt to your incoming workflow demands – whether it be batch, continuous, single slide or STAT cases, or a combination of all the above.

Coupled with the ability to produce high-quality, crisp, clean staining with an average IHC TAT of 90 minutes, the BOND-PRIME staining platform lets you transcend expectations for quality, timeliness, and diagnostic productivity.

Read more about BOND-PRIME here. This solution may not be available in your country. For In Vitro Diagnostic Use.

About Leica Biosystems

Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Visit LeicaBiosystems.com for more information.